Ratings by BTIG (Julian Harrison)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2026 | Apogee Therapeutics Inc | APGE | Downgrade | Neutral (Buy) |
134.69 (135.08) |
0.29% | Details | |
| 7/27/2026 | Outlook Therapeutics Inc. | OTLK | Upgrade | Buy (Neutral) |
1.40 (0.62) |
-55.71% | Details | |
| 6/30/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Theravance Biopharma | TBPH | Downgrade | Neutral (Buy) |
17.63 (17.03) |
-3.4% | Details | |
| 6/11/2026 | Climb Bio | CLYM | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2026 | Outlook Therapeutics Inc. | OTLK | Downgrade | Neutral (Buy) |
0.23 (1.40) |
508.7% | Details | |
| 5/11/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | United Therapeutics Corp. | UTHR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/27/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2026 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2026 | Climb Bio | CLYM | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Connect Biopharma Holdings Ltd | CNTB | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Avalo Therapeutics Inc. | AVTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2026 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2026 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Cartesian Therapeutics | RNAC | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Jade Biosciences | JBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Moonlake Immunotherapeutics | MLTX | Upgrade | Buy (Neutral) |
14.34 (15.13) |
5.51% | Details | |
| 1/9/2026 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | Progenity Inc. | PROG | Upgrade | Neutral (Sell) |
0.88 (0.88) |
0% | Details | |
| 11/14/2025 | Cartesian Therapeutics | RNAC | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Buy (Sell) |
1.55 (2.36) |
52.26% | Details | |
| 10/29/2025 | United Therapeutics Corp. | UTHR | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2025 | Progenity Inc. | PROG | Maintain | Sell (N/A) |
|
Details | ||
| 10/13/2025 | Tvardi Therapeutics Inc | TVRD | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2025 | Jade Biosciences | JBIO | New Coverage | Buy (N/A) |
9.08 (21.02) |
131.5% | Details | |
| 9/30/2025 | Climb Bio | CLYM | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | Moonlake Immunotherapeutics | MLTX | Downgrade | Neutral (Buy) |
61.99 (14.34) |
-76.87% | Details | |
| 9/17/2025 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2025 | Maze Therapeutics | MAZE | New Coverage | Buy (N/A) |
14.49 (26.53) |
83.09% | Details | |
| 8/26/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | VYNE Therapeutics | VYNE | Downgrade | Neutral (Buy) |
1.44 (28.56) |
1883.33% | Details | |
| 7/10/2025 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2025 | VYNE Therapeutics | VYNE | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Avalo Therapeutics Inc. | AVTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2025 | Cartesian Therapeutics | RNAC | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Rezolute | rzlt | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Tvardi Therapeutics Inc | TVRD | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2025 | Climb Bio | CLYM | New Coverage | Buy (N/A) |
1.21 (14.82) |
1124.79% | Details | |
| 5/22/2025 | Oruka Therapeutics | ORKA | New Coverage | Buy (N/A) |
10.58 (92.11) |
770.6% | Details | |
| 5/21/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2025 | Tvardi Therapeutics Inc | TVRD | New Coverage | Buy (N/A) |
26.35 (1.75) |
-93.36% | Details | |
| 5/12/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2025 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2025 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2025 | Nektar Therapeutics | NKTR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/10/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
5.08 (3.76) |
-25.98% | Details | |
| 3/3/2025 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2024 | Avalo Therapeutics Inc. | AVTX | New Coverage | Buy (N/A) |
9.28 (18.95) |
104.2% | Details | |
| 12/19/2024 | Cartesian Therapeutics | RNAC | New Coverage | Buy (N/A) |
16.92 (9.30) |
-45.04% | Details | |
| 12/12/2024 | Keros Therapeutics | KROS | Downgrade | Neutral (Buy) |
68.65 (11.07) |
-83.87% | Details | |
| 12/10/2024 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2024 | Rezolute | RZLT | Maintain | Neutral (N/A) |
|
Details | ||
| 12/2/2024 | AnaptysBio | ANAB | Downgrade | Neutral (Buy) |
24.96 (55.28) |
121.47% | Details | |
| 11/29/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2024 | Protagonist Therapeutics | PTGX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2024 | Aclaris Therapeutis | ACRS | Upgrade | Buy (Neutral) |
2.05 (6.02) |
193.66% | Details | |
| 11/18/2024 | VYNE Therapeutics | VYNE | New Coverage | Buy (N/A) |
2.70 (1.44) |
-46.67% | Details | |
| 10/29/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2024 | Aura Biosciences | AURA | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2024 | Nektar Therapeutics | NKTR | New Coverage | Buy (N/A) |
1.17 (71.75) |
6032.48% | Details | |
| 9/30/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2024 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2024 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2024 | Aclaris Therapeutis | ACRS | Maintain | Neutral (N/A) |
|
Details | ||
| 9/18/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2024 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
16.77 (21.79) |
29.93% | Details | |
| 7/24/2024 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2024 | Rezolute | RZLT | New Coverage | Buy (N/A) |
4.78 (4.50) |
-5.86% | Details | |
| 7/15/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Aerovate Therapeutics Inc | AVTE | Downgrade | Neutral (Buy) |
24.62 (2.68) |
-89.11% | Details | |
| 6/11/2024 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2024 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2024 | Theravance Biopharma | TBPH | New Coverage | Buy (N/A) |
8.93 (17.63) |
97.42% | Details | |
| 3/27/2024 | Outlook Therapeutics Incs. | OTLK | Upgrade | Buy (Neutral) |
8.68 (0.23) |
-97.35% | Details | |
| 3/7/2024 | Zealand Pharma A/S | ZEAL | New Coverage | Buy (N/A) |
17.59 (17.59) |
0% | Details | |
| 3/5/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | AnaptysBio | ANAB | New Coverage | Buy (N/A) |
25.87 (55.28) |
113.68% | Details | |
| 2/13/2024 | CymaBay Therapeutic | CBAY | Downgrade | Neutral (Buy) |
32.21 (32.48) |
0.84% | Details | |
| 1/11/2024 | Aclaris Therapeutis | ACRS | Downgrade | Neutral (Buy) |
1.01 (2.05) |
102.97% | Details | |
| 12/21/2023 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
23.22 (134.69) |
480.06% | Details | |
| 12/20/2023 | Spyre | SYRE | New Coverage | Buy (N/A) |
16.40 (88.50) |
439.63% | Details | |
| 12/18/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2023 | Aura Biosciences | AURA | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2023 | Akebia Therapeutics | AKBA | New Coverage | Buy (N/A) |
0.96 (0.94) |
-2.08% | Details | |
| 11/13/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2023 | Mereo BipPharma Group | MREO | New Coverage | Buy (N/A) |
1.29 (0.28) |
-78.29% | Details | |
| 9/25/2023 | Morphic Therapeutic | MORF | Downgrade | Neutral (Buy) |
36.68 (56.99) |
55.37% | Details | |
| 9/8/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2023 | Outlook Therapeutics Incs. | OTLK | Downgrade | Neutral (Buy) |
1.41 (0.62) |
-56.03% | Details | |
| 8/11/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2023 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2023 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
26.54 (23.03) |
-13.23% | Details | |
| 4/26/2023 | Morphic Therapeutic | MORF | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2023 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
5.38 (0.86) |
-84.01% | Details | |
| 4/17/2023 | Paratek Pharmaceuticals | PRTK | New Coverage | Buy (N/A) |
2.73 (2.23) |
-18.32% | Details | |
| 4/17/2023 | Matinas BioPharma Holdings Inc. | MTNB | New Coverage | Buy (N/A) |
0.44 (0.20) |
-54.55% | Details | |
| 4/17/2023 | Aura Biosciences | AURA | New Coverage | Buy (N/A) |
8.64 (7.43) |
-14% | Details | |
| 4/17/2023 | Prometheus Biosciences Inc | RXDX | Downgrade | Neutral (Buy) |
112.86 (199.92) |
77.14% | Details | |
| 3/6/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Outlook Therapeutics Incs. | OTLK | New Coverage | Buy (N/A) |
1.20 (1.41) |
17.5% | Details | |
| 10/6/2022 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
15.75 (6.02) |
-61.78% | Details | |
| 10/3/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2022 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2022 | Keros Therapeutics | KROS | New Coverage | Buy (N/A) |
28.53 (68.65) |
140.62% | Details | |
| 7/20/2022 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2022 | Liquidia Technologies | LQDA | New Coverage | Buy (N/A) |
4.07 (66.91) |
1543.98% | Details | |
| 5/3/2022 | Progenity Inc. | PROG | New Coverage | Buy (N/A) |
0.84 (0.88) |
4.76% | Details | |
| 4/26/2022 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2020 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2020 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2020 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2020 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
5.76 (33.67) |
484.55% | Details | |
| 5/1/2020 | Axcella Health Inc. | AXLA | New Coverage | Buy (N/A) |
4.66 (4.58) |
-1.72% | Details |
